RCEL
RCEL
NASDAQ · Biotechnology

Avita Medical Inc

$3.89
+0.19 (+5.14%)
As of Apr 1, 3:00 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target +789.7% upside
Low Target $23.82
Average Target $34.61
High Target $34.97
Current Price $3.89
Current
$3.89
Target
$34.61
$23.82 $34.61 avg $34.97
Scenario Analysis
Bear Case
$23.82
512.3%
Low target
Base Case
$34.61
+789.7%
Avg target
Bull Case
$34.97
+799.0%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$10.29
-62.2% from high
52-Week Low
$3.22
+20.8% from low
Target vs 52W High
$34.61
+236.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%